P Moingeon

Author PubWeight™ 56.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity. Nature 1987 2.48
2 A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells. Cell 1992 2.08
3 The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008 1.96
4 A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature 1986 1.90
5 Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 2008 1.71
6 Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy. Clin Exp Allergy 2009 1.56
7 Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity. Hum Gene Ther 1998 1.54
8 Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4⁺ T cells. Clin Exp Allergy 2011 1.53
9 Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes. EMBO J 1988 1.47
10 A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 1993 1.33
11 Triggering of T-lymphocytes via either T3-Ti or T11 surface structures opens a voltage-insensitive plasma membrane calcium-permeable channel: requirement for interleukin-2 gene function. J Biol Chem 1989 1.28
12 Natural killer clones derived from fetal (25 wk) blood. Probing the human T cell receptor with WT31 monoclonal antibody. J Exp Med 1986 1.21
13 Proliferative responses of circulating human NK cells: delineation of a unique pathway involving both direct and helper signals. Eur J Immunol 1985 1.18
14 Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy 2011 1.18
15 Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status. J Exp Med 1993 1.16
16 Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production. J Exp Med 1989 1.13
17 Delineation of a T-cell activation motif required for binding of protein tyrosine kinases containing tandem SH2 domains. Proc Natl Acad Sci U S A 1994 1.07
18 Phosphorylation of multiple CD3 zeta tyrosine residues leads to formation of pp21 in vitro and in vivo. Structural changes upon T cell receptor stimulation. J Biol Chem 1992 1.02
19 Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses. Clin Exp Allergy 2010 1.01
20 Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation. Allergy 2009 1.00
21 Recombinant viruses as a tool for therapeutic vaccination against human cancers. Immunol Lett 2000 0.99
22 The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation. J Exp Med 1992 0.96
23 Involvement of the PPPGHR motif in T cell activation via CD2. J Exp Med 1990 0.93
24 Benzodiazepine receptors on human blood platelets. Life Sci 1984 0.93
25 Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells. Clin Exp Allergy 2009 0.93
26 Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 2003 0.91
27 A target structure for a series of human cloned natural killer cell lines is recognized by both anti-TNKtar and 4F2 monoclonal antibodies. J Immunol 1985 0.90
28 Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice. Mucosal Immunol 2011 0.90
29 Production of native and modified recombinant Der p 1 molecules in tobacco plants. Clin Exp Allergy 2009 0.89
30 Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy. Clin Exp Allergy 2012 0.88
31 A fraction of CD3 epsilon subunits exists as disulfide-linked dimers in both human and murine T lymphocytes. J Biol Chem 1990 0.87
32 Deletion of the cytoplasmic region of the CD3 epsilon subunit does not prevent assembly of a functional T-cell receptor. Proc Natl Acad Sci U S A 1989 0.87
33 Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. Allergy 2009 0.87
34 Therapeutic vaccines against melanoma and colorectal cancer. Vaccine 2001 0.85
35 Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 1986 0.83
36 Cancer vaccines based on dendritic cells loaded with tumor-associated antigens. Cell Biol Toxicol 2001 0.82
37 Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques. Vaccine 2001 0.81
38 Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies. Pharmeur Bio Sci Notes 2012 0.80
39 Characterization of a peripheral-type benzodiazepine binding site on human circulating lymphocytes. Eur J Pharmacol 1983 0.80
40 Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy. Allergy 2011 0.80
41 Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int J Immunopathol Pharmacol 2008 0.80
42 Advances in the quantification of relevant allergens in allergenic extracts. Eur Ann Allergy Clin Immunol 2013 0.79
43 Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53. Cancer Gene Ther 2001 0.79
44 Respiratory allergen from house dust mite is present in human milk and primes for allergic sensitization in a mouse model of asthma. Allergy 2013 0.78
45 Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy. Clin Exp Allergy 2013 0.78
46 Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantation. Transplantation 1986 0.78
47 Generation of monoclonal antibodies blocking cytotoxic reactions by human NK clones: further characterization of a 40/80-kDa target cell receptor. Cell Immunol 1986 0.78
48 Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation. Clin Exp Allergy 2011 0.78
49 Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells. Allergy 2015 0.77
50 The biology of human CD2. Cold Spring Harb Symp Quant Biol 1989 0.76
51 In vivo modulation of muscarine receptors in rat brain by acute lead intoxication. Toxicology 1984 0.76
52 Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy. Clin Exp Allergy 2012 0.76
53 Oral reactions to sublingual immunotherapy: a bioptic study. Allergy 2007 0.75
54 Anti-inflammatory activity of sublingual immunoglobulin (SLIG) in a murine model of allergen-driven airway inflammation. Vaccine 2012 0.75
55 Two-dimensional electrophoretic analysis of cytosols from human breast tumors: optimal migration conditions. Clin Chem 1984 0.75
56 Effect of antidepressant and narcoleptic drugs on N-isopropyl p-iodoamphetamine biodistribution in animals. J Nucl Med 1987 0.75
57 Inhibition of acetylcholinesterase and cholinesterase by ellipticine derivatives. Biochem Pharmacol 1983 0.75
58 Ellipticine derivatives interact with muscarinic receptors. Biochem Pharmacol 1985 0.75
59 Allogeneic responses of human fetal (22- to 25-week) peripheral blood lymphocytes: preferential recruitment of cytotoxic effector cells with both CTL activity and NK-like function. Cell Immunol 1986 0.75
60 Short-term culture of acute myeloid leukemia blasts: analysis of acquired susceptibility to activated natural killer cells. Blood 1986 0.75
61 Muscarinic cholinergic receptors on circulating human lymphocytes: evidence for a particulate binding site. Res Commun Chem Pathol Pharmacol 1983 0.75
62 A fraction of CD3 epsilon subunits exists as disulfide-linked dimers in both human and murine T lymphocytes. J Biol Chem 1990 0.75